Bispride P 2mg/500mg/15mg Tablet SR
Marketer
Zenni Pharmaceutical Private Limited
Salt Composition
Glimepiride (2mg) + Metformin (500mg) + Pioglitazone (15mg)
Overview Bispride P 2mg/500mg/15mg Tablet SR
Tri-Active Diabetica 2mg/500mg/15mg Extended-Release Tablets are a combined medication designed to manage blood glucose. This formulation, used alongside diet and exercise, enhances glycemic control in adult patients with type 2 diabetes. It promotes efficient insulin utilization, resulting in reduced blood sugar. Tri-Active Diabetica should be ingested as prescribed, adhering to the recommended dosage and duration. To minimize gastrointestinal discomfort, it's crucial to take it with food. Missed doses should be taken promptly, unless nearing the next scheduled dose, in which case it should be omitted. Never double the dose. An overdose can induce hypoglycemia (low blood sugar). Concomitant use with other antidiabetic medications, alcohol, or skipped meals may increase hypoglycemia risk; diligent blood glucose monitoring is essential. Common side effects include nausea, diarrhea, abdominal pain, headache, bone fractures, and respiratory infections. Prior to initiating treatment, disclose any kidney, liver, or heart conditions to your physician. Pregnant or lactating women require medical consultation before use. Renal function will be assessed prior to treatment commencement. Limit alcohol consumption to mitigate potential adverse reactions.
Uses of Bispride P 2mg/500mg/15mg Tablet SR
Managing Type 2 diabetes
Major Benefits of Bispride P 2mg/500mg/15mg Tablet SR:
Administer this medication precisely as prescribed by your physician, adhering to both the dosage and treatment schedule. Ingest the entire tablet without chewing, crushing, or fracturing. Consume Bispride P 2mg/500mg/15mg Extended-Release tablets with a meal.
Common Side effects of Bispride P 2mg/500mg/15mg Tablet SR:
- Hypoglycemia (low blood glucose level)
- Headache
- Nausea
- Diarrhea
- Dizziness
- Vomiting
- Anemia (low number of red blood cells)
- Weakness
- Sinus infection
How to use Bispride P 2mg/500mg/15mg Tablet SR:
Administer this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment length. Ingest the entire tablet without chewing, crushing, or dividing it. Consume Bispride P 2mg/500mg/15mg Extended-Release tablets with food.
How Bispride P 2mg/500mg/15mg Tablet SR works:
Bispride P 2mg/500mg/15mg Extended-Release tablets combine glimepiride, metformin, and pioglitazone—three distinct antidiabetic agents. Their synergistic action enhances blood glucose management when monotherapy or dual therapy proves insufficient. Glimepiride, a sulfonylurea, stimulates pancreatic insulin secretion to reduce blood sugar. Metformin, a biguanide, acts by decreasing hepatic glucose production, slowing intestinal glucose absorption, and improving insulin responsiveness. Pioglitazone, a thiazolidinedione, further augments insulin sensitivity.
SAFETY ADVICE
AlcoholUNSAFE
Consuming alcohol while taking Bispride P 2mg/500mg/15mg SR tablets is unsafe.
PregnancyCONSULT YOUR DOCTOR
The use of Bispride P 2mg/500mg/15mg SR tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a fetus. A physician will assess the advantages against possible risks prior to prescribing. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
Prolonged-release Bispride P tablets (2mg/500mg/15mg) are likely unsuitable for breastfeeding mothers. Available evidence from human studies indicates potential transfer to breast milk with consequent risk to the infant.
DrivingCAUTION
Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.
KidneyCAUTION
Exercise caution when administering Bispride P 2mg/500mg/15mg SR tablets to individuals with impaired renal function; dosage modification may be necessary. Consult a physician for guidance. Bispride P 2mg/500mg/15mg SR tablets are contraindicated in patients exhibiting severe kidney disease. Regular monitoring of renal function is recommended during treatment.
LiverCAUTION
Patients with liver impairment should use Bispride P 2mg/500mg/15mg SR tablets cautiously, potentially requiring dose modification. Consultation with a physician is advised. Bispride P 2mg/500mg/15mg SR tablets are contraindicated in individuals with severe hepatic dysfunction.
What if you forget to take Bispride P 2mg/500mg/15mg Tablet SR :
Should you forget to take your Bispride P 2mg/500mg/15mg SR Tablet, administer it immediately upon remembrance. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Bispride P 2mg/500mg/15mg Tablet SR
| Label | Value |
|---|---|
| Developing Habits | No. |
| Type of Therapy | Diabetes Management |
3,018 People bought this recently